LISATA THERAPEUTICS, INC. Revenue Breakdown
No Revenue Breakdown for LSTA on this site yet.
- 2025-12-31: Total revenue $170.00K.
- 2024-12-31: Others Not split by product in the filing$1.00M100.00%; Total revenue $1.00M.
- 2023-12-31: Total revenue $0.00.
- 2022-12-31: Total revenue $0.00.
Source checked: the stored Revenue Breakdown page for LSTA.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | $170.00K | |
| 2024-12-31 | Not split by product in the filing $1.00M 100.00% | $1.00M |
| 2023-12-31 | $0.00 | |
| 2022-12-31 | $0.00 | |
| 2016-12-31 | Not split by product in the filing $35.28M 100.00% | $35.28M |
| 2015-12-31 | Not split by product in the filing $22.49M 100.00% | $22.49M |
| 2014-12-31 | Not split by product in the filing $17.94M 100.00% | $17.94M |
| 2013-12-31 | Not split by product in the filing $14.67M 100.00% | $14.67M |
| 2012-12-31 | Not split by product in the filing $14.33M 100.00% | $14.33M |
| 2011-12-31 | Not split by product in the filing $10.05M 100.00% | $10.05M |
| 2010-12-31 | $181.15K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $0.00 | $0.00 |
| 2026-03-31 | Not split by product $0.00 | $0.00 |
| 2025-12-31 | Not split by product $100.00K 100.00% | $100.00K |
| 2025-09-30 | Not split by product $0.00 | $0.00 |
| 2025-06-30 | Not split by product $70.00K 100.00% | $70.00K |
| 2025-03-31 | Not split by product $0.00 | $0.00 |
| 2024-12-31 | Not split by product $1.00M 100.00% | $1.00M |
| 2024-09-30 | Not split by product $0.00 | $0.00 |
| 2024-06-30 | Not split by product $0.00 | $0.00 |
| 2024-03-31 | Not split by product $0.00 | $0.00 |
| 2023-12-31 | Not split by product $0.00 | $0.00 |
| 2023-09-30 | Not split by product $0.00 | $0.00 |
| 2023-06-30 | Not split by product $0.00 | $0.00 |
| 2023-03-31 | Not split by product $0.00 | $0.00 |
| 2022-12-31 | Not split by product $0.00 | $0.00 |
| 2022-09-30 | Not split by product $0.00 | $0.00 |
| 2017-03-31 | Not split by product $7.92M 100.00% | $7.92M |
| 2016-12-31 | Not split by product $10.18M 100.00% | $10.18M |
| 2016-09-30 | Not split by product $9.32M 100.00% | $9.32M |
| 2016-06-30 | Not split by product $8.30M 100.00% | $8.30M |
| 2016-03-31 | Not split by product $7.49M 100.00% | $7.49M |
| 2015-12-31 | Not split by product $7.56K 100.00% | $7.56K |
| 2015-09-30 | Not split by product $5.89M 100.00% | $5.89M |
| 2015-06-30 | Not split by product $5.87M 100.00% | $5.87M |
| 2015-03-31 | Not split by product $3.17M 100.00% | $3.17M |
| 2014-12-31 | Not split by product $5.28K 100.00% | $5.28K |
| 2014-09-30 | Not split by product $4.12K 100.00% | $4.12K |
| 2014-06-30 | Not split by product $4.49K 100.00% | $4.49K |
| 2014-03-31 | Not split by product $4.06K 100.00% | $4.06K |
| 2013-12-31 | Not split by product $4.08K 100.00% | $4.08K |
| 2013-09-30 | Not split by product $3.71K 100.00% | $3.71K |
| 2013-06-30 | Not split by product $4.36K 100.00% | $4.36K |
| 2013-03-31 | Not split by product $2.52K 100.00% | $2.52K |
| 2012-12-31 | Not split by product $2.75M 100.00% | $2.75M |
| 2012-09-30 | Not split by product $4.43M 100.00% | $4.43M |
| 2012-06-30 | Not split by product $3.37M 100.00% | $3.37M |
| 2012-03-31 | Not split by product $3.77M 100.00% | $3.77M |
| 2011-12-31 | Not split by product $4.21M 100.00% | $4.21M |
| 2011-09-30 | Not split by product $2.18M 100.00% | $2.18M |
| 2011-06-30 | Not split by product $2.21M 100.00% | $2.21M |
| 2011-03-31 | Not split by product $19.59M 100.00% | $19.59M |
| 2010-12-31 | Not split by product -$51.54M 100.00% | -$51.54M |
| 2010-09-30 | Not split by product $16.48M 100.00% | $16.48M |
| 2010-06-30 | Not split by product $19.41M 100.00% | $19.41M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |